Last reviewed · How we verify
NCT05079802: LSTR
Clinical & Radiographic Evaluation of LSTR in Non-vital Primary Molars Using Two Different Vehicles
Phase 3 trial testing Double antibiotic paste mixed with chitosan nanoparticles in Resorption of Tooth or Root in 36 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 December 2021 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 March 2024 |
Drugs / interventions tested
- Double antibiotic paste mixed with chitosan nanoparticles — full drug profile →
- Double antibiotic paste mixed with propylene glycol — full drug profile →
Conditions studied
- Resorption of Tooth or Root — all drugs for Resorption of Tooth or Root →
Sponsor
Ain Shams University
Who can join
Adults 4 to 7, any sex, with Resorption of Tooth or Root. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
LSTR will be done for primary teeth with significant root resorption needing non-vital pulp therapy to save such teeth for up to 12 months. The first part will be in vitro study to compare the antimicrobial effect of double antibiotic paste mixed with chitosan nanoparticle vs double antibiotic paste mixed with propylene glycol. The second part will be randomized clinical trial comparing the clinical and radiographic success of LSTR in study group where double antibiotic mix is mixed with chitosan nanoparticles and control group where double antibiotic paste is mixed with propylene glycol .
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance.
León-Buitimea A, Garza-Cárdenas CR, Román-García MF, Ramírez-Díaz CA, et al · · 2022 · cited 23× · PMID 35740200 · DOI 10.3390/antibiotics11060794 -
Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases.
Sinani G, Sessevmez M, Şenel S. · · 2024 · cited 16× · PMID 39339237 · DOI 10.3390/pharmaceutics16091201 -
Chitosan Micro/Nanocapsules in Action: Linking Design, Production, and Therapeutic Application.
Pérez-Pacheco Y, Tylkowski B, García-Valls R. · · 2025 · cited 12× · PMID 39860124 · DOI 10.3390/molecules30020252
Verify or expand the search:
- PubMed search for NCT05079802
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05079802 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 8 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05079802.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing